Clinical Trial

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Name: A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis — clinical trial record (NCT06072482)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Protocol Amendment History 1 change

notable Trial sites expanded: 68 -> 76 locations 2026-04-29

Trial Details

NCT Number	NCT06072482
Lead Sponsor	Amgen
Conditions	Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment	300 participants
Start Date	2024-02-07
Primary Completion	2036-12-31 (estimated)
Study Completion	2036-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-16